Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial

Journal:
Nature Medicine
Published:
DOI:
10.1038/s41591-026-04366-x
Affiliations:
2
Authors:
17
Go to article
Institutions Authors Share
Haihe Laboratory of Cell Ecosystem, China
8.500000
 0.50
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), China
8.500000
 0.50
Interested in Immunology?